Varex Imaging (VREX) Cash & Equivalents (2016 - 2026)

Varex Imaging (VREX) has reported Cash & Equivalents for 11 consecutive years, with $99.2 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Cash & Equivalents fell 27.27% year-over-year to $99.2 million in Q3 2026; TTM through Jul 2026 was $99.2 million, a 27.27% decrease from a year earlier, with the FY2025 full-year figure at $145.0 million, down 14.05% from the prior year.
• Cash & Equivalents was $99.2 million for Q3 2026 at Varex Imaging, up from $85.3 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $205.1 million in Q2 2025 and troughed at $81.5 million in Q4 2022.
• A 5-year average of $129.8 million and a median of $128.0 million in 2025 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents jumped 73.37% in 2023 and slumped 58.41% in 2026, its largest moves.
• Over 5 years, Cash & Equivalents stood at $81.5 million in 2022, then jumped by 73.37% to $141.3 million in 2023, then climbed by 19.39% to $168.7 million in 2024, then slipped by 14.05% to $145.0 million in 2025, then slumped by 31.59% to $99.2 million in 2026.
• The last three Cash & Equivalents figures came in at $99.2 million (Q3 2026), $85.3 million (Q2 2026), and $119.5 million (Q1 2026), per Business Quant data.